Home › Funds › ORBIMED ADVISORS LLC › AXSM
ORBIMED ADVISORS LLC position in AXSM
AXSOME THERAPEUTICS INC. · Health Care
ORBIMED ADVISORS LLC reported holding 117,578 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q2 2026 13F filing — a position valued at US$28.8M, representing 0.58% of its reported portfolio and ranking #45 among its reported holdings. ORBIMED ADVISORS LLC has disclosed AXSM holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's AXSM position evolved
ORBIMED ADVISORS LLC first disclosed a stake in AXSM in Q1 2025 at 386,700 shares (US$45.1M). The position peaked in Q3 2025 at 531,800 shares, worth US$64.6M. Across 6 filings, ORBIMED ADVISORS LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 117,578 shares valued at US$28.8M — a reduction of -96,343 shares quarter over quarter.. Notable position changes include a 52% trim in Q4 2025 (shares fell 7% over the following quarter), a 45% trim in Q2 2026 (shares fell 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 386.70K | $45.10M | New |
| Q2 2025 | 427.90K | $44.67M | Add |
| Q3 2025 | 531.80K | $64.59M | Add |
| Q4 2025 | 253.12K | $46.23M | Reduce |
| Q1 2026 | 213.92K | $36.16M | Reduce |
| Q2 2026 | 117.58K | $28.78M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AXSM and 13F data
AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 54 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$158.8M), Hood River Capital Management LLC (US$98.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AXSM
- Deep Track Capital, LP 700.00K sh · $171.34M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 648.76K sh · $158.80M · Q2 2026
- Hood River Capital Management LLC 402.68K sh · $98.56M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 316.82K sh · $77.53M · Q2 2026
- Integral Health Asset Management, LLC 300.00K sh · $73.43M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K sh · $62.24M · Q2 2026
- SAMLYN CAPITAL, LLC 246.01K sh · $60.22M · Q2 2026
- PFM Health Sciences, LP 219.60K sh · $53.75M · Q2 2026
- Tri Locum Partners LP 219.31K sh · $53.68M · Q2 2026
- First Turn Management, LLC 218.41K sh · $53.46M · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held AXSM?
ORBIMED ADVISORS LLC has disclosed AXSM holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is ORBIMED ADVISORS LLC's current position in AXSM?
As of Q2 2026, ORBIMED ADVISORS LLC holds 117.58K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $28.78M, representing 0.58% of its reported portfolio and ranking #45.
Has ORBIMED ADVISORS LLC been buying or selling AXSM?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC reduced its position in AXSM. The position peaked in Q3 2025 at 531.80K shares.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.